Current knowledge on cannabinoids in oral fluid

被引:79
作者
Lee, Dayong [1 ]
Huestis, Marilyn A. [1 ]
机构
[1] Natl Inst Drug Abuse, Natl Inst Hlth, Chem & Drug Metab Intramural Res Program, Baltimore, MD 21224 USA
关键词
oral fluid; cannabis; delta-9-tetrahydrocannabinol; marijuana; saliva; cannabinoid; ILLICIT DRUG-USE; PERFORMANCE LIQUID-CHROMATOGRAPHY; EXTERNAL QUALITY ASSESSMENT; POSITIVE PREVALENCE RATES; SOLID-PHASE EXTRACTION; CHRONIC PAIN; GAS-CHROMATOGRAPHY; 11-NOR-DELTA(9)-TETRAHYDROCANNABINOL-9-CARBOXYLIC ACID; DELTA(9)-TETRAHYDROCANNABINOL THC; MARIJUANA USE;
D O I
10.1002/dta.1514
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Oral fluid (OF) is a new biological matrix for clinical and forensic drug testing, offering non-invasive and directly observable sample collection reducing adulteration potential, ease of multiple sample collections, lower biohazard risk during collection, recent exposure identification, and stronger correlation with blood than urine concentrations. Because cannabinoids are usually the most prevalent analytes in illicit drug testing, application of OF drug testing requires sufficient scientific data to support sensitive and specific OF cannabinoid detection. This review presents current knowledge of OF cannabinoids, evaluating pharmacokinetic properties, detection windows, and correlation with other biological matrices and impairment from field applications and controlled drug administration studies. In addition, onsite screening technologies, confirmatory analytical methods, drug stability, and effects of sample collection procedure, adulterants, and passive environmental exposure are reviewed. Delta-9-tetrahydrocannabinol OF concentrations could be >1000 mu g/L shortly after smoking, whereas minor cannabinoids are detected at 10-fold and metabolites at 1000-fold lower concentrations. OF research over the past decade demonstrated that appropriate interpretation of test results requires a comprehensive understanding of distinct elimination profiles and detection windows for different cannabinoids, which are influenced by administration route, dose, and drug use history. Thus, each drug testing program should establish cut-off criteria, collection/analysis procedures, and storage conditions tailored to its purposes. Building a scientific basis for OF testing is ongoing, with continuing OF cannabinoids research on passive environmental exposure, drug use history, donor physiological conditions, and oral cavity metabolism needed to better understand mechanisms of cannabinoid OF disposition and expand OF drug testing applicability. Published 2013. This article is a U.S. Government work and is in the public domain in the USA.
引用
收藏
页码:88 / 111
页数:24
相关论文
共 247 条
[71]   Estimating equivalent cutoff thresholds for drugs in blood and oral fluid using prevalence regression: A study of tetrahydrocannabinol and amphetamine [J].
Gjerde, Hallvard ;
Verstraete, Alain G. .
FORENSIC SCIENCE INTERNATIONAL, 2011, 212 (1-3) :E26-E30
[72]   The Prevalence of Alcohol and Drugs in Sampled Oral Fluid is Related to Sample Volume [J].
Gjerde, Hallvard ;
Normann, Per T. ;
Christophersen, Asbjorg S. .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2010, 34 (07) :416-419
[73]   Use of alcohol and drugs by Norwegian employees: a pilot study using questionnaires and analysis of oral fluid [J].
Gjerde, Hallvard ;
Christophersen, Asbjorg S. ;
Moan, Inger S. ;
Yttredal, Borghild ;
Walsh, J. Michael ;
Normann, Per T. ;
Morland, Jorg .
JOURNAL OF OCCUPATIONAL MEDICINE AND TOXICOLOGY, 2010, 5
[74]   Comparison of Drug Concentrations in Blood and Oral Fluid Collected with the Intercept® Sampling Device [J].
Gjerde, Hallvard ;
Mordal, Jon ;
Christophersen, Asbjorg S. ;
Bramness, Jorgen G. ;
Morland, Jorg .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2010, 34 (04) :204-209
[75]   The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors [J].
Gomes, Felipe V. ;
Resstel, Leonardo B. M. ;
Guimaraes, Francisco S. .
PSYCHOPHARMACOLOGY, 2011, 213 (2-3) :465-473
[76]  
GREENE ML, 1974, GASTROENTEROLOGY, V66, P365
[77]   Measuring substance use in the club setting: a feasibility study using biochemical markers [J].
Gripenberg-Abdon, Johanna ;
Elgan, Tobias H. ;
Wallin, Eva ;
Shaafati, Marjan ;
Beck, Olof ;
Andreasson, Sven .
SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2012, 7
[78]  
GROSS SJ, 1985, J ANAL TOXICOL, V9, P1
[79]   Pharmacokinetics and pharmacodynamics of cannabinoids [J].
Grotenhermen, F .
CLINICAL PHARMACOKINETICS, 2003, 42 (04) :327-360
[80]   Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography/electron impact mass spectrometry [J].
Gunnar, T ;
Ariniemi, K ;
Lillsunde, P .
JOURNAL OF MASS SPECTROMETRY, 2005, 40 (06) :739-753